Comparison of postoperative nausea and vomiting between remimazolam and propofol: a propensity score-matched, retrospective, observational, single-center cohort study

BACKGROUND: Remimazolam is a novel ultrashort-acting benzodiazepine that has recently become available for general anesthesia. However, the incidence of postoperative nausea and vomiting (PONV) associated with remimazolam remains unknown. In this propensity score-matched, retrospective, observationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Yuji, Kawashima, Shingo, Makino, Hiroshi, Doi, Matsuyuki, Nakajima, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Anesthesiologists 2023
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079003/
https://www.ncbi.nlm.nih.gov/pubmed/36245344
http://dx.doi.org/10.4097/kja.22441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079003/
https://www.ncbi.nlm.nih.gov/pubmed/36245344
http://dx.doi.org/10.4097/kja.22441

Ejemplares similares